Related Experiment Video
Updated: Mar 21, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Clinical efficacy of tiotropium in children with asthma
Juan Huang1, Ying Chen2, Zhen Long3
1Juan Huang, Department of Pediatric Internal Medicine, Hubei Maternal and Child Health Care Hospital, Wuhan 430072, China.
Insights
Tiotropium improved lung function and sleep in children with asthma. It also reduced the need for rescue inhalers, demonstrating its clinical efficacy with few adverse effects.
Area of Science:
- Pediatric Pulmonology
- Pharmacology
Background:
- Asthma is a chronic respiratory condition affecting children worldwide.
- Current treatments for pediatric asthma include inhaled corticosteroids and short-acting bronchodilators.
Purpose of the Study:
- To evaluate the clinical effectiveness of tiotropium as an add-on therapy for moderate persistent asthma in children.
- To assess the impact of tiotropium on lung function, symptom control, and safety in pediatric asthma patients.
Main Methods:
- A randomized controlled trial involving 80 children with newly diagnosed moderate persistent asthma.
- Participants were assigned to receive either fluticasone propionate aerosol alone or in combination with tiotropium for 12 weeks.
Main Results:
- Tiotropium add-on therapy significantly improved lung function compared to fluticasone alone.
- Patients receiving tiotropium showed a significant reduction in short-acting beta2-adrenoceptor agonist use and nighttime awakenings.
- No significant difference in severe asthma exacerbations or severe adverse reactions was observed between groups.
Conclusions:
- Tiotropium is an effective add-on treatment for pediatric asthma, enhancing lung function and symptom control.
- The addition of tiotropium to fluticasone propionate improves quality of life by reducing rescue medication use and sleep disturbances.
- Tiotropium demonstrates a favorable safety profile in children with asthma.
Objective:
To investigate the clinical efficacy of tiotropium in children with asthma.
Methods:
Eighty children with newly diagnosed moderate persistent asthma were enrolled into this study. The children were randomly assigned to the fluticasone propionate aerosol group or the fluticasone propionate aerosol plus tiotropium group for 12 weeks.
Results:
Lung function was significantly improved in both groups at 4, 8, and 12 weeks compared with baseline (P < 0.01). Moreover, lung function was significantly improved in the tiotropium group compared with the control group (P < 0.05). However, there was no significant difference in the incidence of severe asthma between the two groups (36.3% and 26.8%, respectively; P > 0.05). Compared with the control group, the number of days and frequency of short-acting beta2-adrenoceptor agonist use was significantly reduced in the tiotropium group (P < 0.05). Awakenings during the night were also significantly decreased (P < 0.00). There were no severe adverse reactions in either of the study groups.
Conclusion:
Tiotropium could significantly improve lung function, reduce the use of short-acting beta2-adrenoceptor agonists, and improve sleep in children with asthma. Furthermore, few adverse reactions were reported.
Related Concept Videos
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:24Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
01:26Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: